Kim et al. recently discovered that the histone deacetylase (HDAC) inhibitor panobinostat is synergistically lethal with ADI-PEG20 in ASS1-low pancreatic cancer (147). This evidence concerns the gene ASS1 and familial pancreatic carcinoma.